SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-028403
Filing Date
2021-05-17
Accepted
2021-05-17 16:19:42
Documents
52
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acer-10q_20210331.htm 10-Q 1551703
2 EX-10.3 acer-ex103_246.htm EX-10.3 310903
3 EX-31.1 acer-ex311_8.htm EX-31.1 17829
4 EX-31.2 acer-ex312_7.htm EX-31.2 17511
5 EX-32.1 acer-ex321_6.htm EX-32.1 7885
6 EX-32.2 acer-ex322_9.htm EX-32.2 7687
7 GRAPHIC gepkqxeobjhc000001.jpg GRAPHIC 5704
8 GRAPHIC gc3hbgci4xho000001.jpg GRAPHIC 17440
  Complete submission text file 0001564590-21-028403.txt   5182133

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT acer-20210331.xml EX-101.INS 674452
10 XBRL TAXONOMY EXTENSION SCHEMA acer-20210331.xsd EX-101.SCH 45202
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acer-20210331_cal.xml EX-101.CAL 34095
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acer-20210331_def.xml EX-101.DEF 143942
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE acer-20210331_lab.xml EX-101.LAB 364221
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acer-20210331_pre.xml EX-101.PRE 263645
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33004 | Film No.: 21930977
SIC: 2834 Pharmaceutical Preparations